7
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Role of CA125 and Abdominal Pelvic Computerized Axial Tomogram in the Monitoring of Chemotherapy Treatment of Ovarian Cancer

, , &
Pages 467-470 | Published online: 11 Jun 2009

References

  • Bast R C, Jr, Klug T L, St. John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl I Med 1983; 309: 883–887
  • Zanaboni F, Vergadoro F, Presti M, et al. Tumor antigen CA125 as a marker of ovarian epithelial carcinoma. Gynecol Oncol 1987; 28: 61–67
  • Crombach G, Zippel H H, Wurz H. Clinical significance of cancer antigen 125 (CA125) in ovarian cancer. Cancer Detect Prevent 1985; 8: 135–139
  • Krebs H B, Gopterud D R, Kilpatrick S J, et al. Role of Ca 125 as a tumor marker in ovarian carcinoma. Obstet Gynecol 1986; 67: 472–477
  • Berek I S, Knapp R C, Malkasian G D, et al. CA125 serum levels correlated with second-look operations among ovarian cancer patients. Obstet Gynecol 1986; 67: 685–689
  • Stehman F B, Calkins A R, Wass J L, et al. A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian cancer. Gynecol Oncol 1988; 29: 37–42
  • Brenner D E, Shaff M I, Jones H W, et al. Abdominopelvic computed tomography: evaluation in patients undergoing second-look laparotomy for ovarian carcinoma. Obstet Gynecol 1985; 65: 715–719
  • Finkler N J, Kapnick S J, Griffiths C T, Knapp R C. Elevated CA125 serum levels and epithelial ovarian cancer metastatic to retroperitoneal lymph nodes. Gynecol Oncol 1988; 29: 356–360

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.